Royal Jelly 2000 mg
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
11-07-2021
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Royal jelly lyophilised, Quantity: 666.67 mg (Equivalent: 10-hydroxy-2-decenoic acid, Qty 40 mg; Equivalent: Royal Jelly fresh, Qty 2 g)
Available from:
Vitex Pharmaceuticals Pty Ltd
Pharmaceutical form:
Capsule, soft
Composition:
Excipient Ingredients: Gelatin; glycerol; yellow beeswax; lecithin; hydrogenated coconut oil; purified water; d-alpha-tocopherol; Soya Oil
Administration route:
Oral
Therapeutic indications:
Maintain/support general health and wellbeing
Product summary:
Visual Identification: ;
Authorization status:
Listed
Authorization date:
2021-07-05
